What is NDC 70710-2169?

70710-2169 is the product NDC for Estradiol and Levonorgestrel, Estradiol .045 mg/d; Levonorgestrel .015 mg/d patch, listed with the FDA by Zydus Pharmaceuticals USA Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

Zydus Pharmaceuticals USA Inc., NDC labeler code 70710. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Estradiol and Levonorgestrel?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Estradiol and Levonorgestrel NDC 70710-2169

NDC codes

FDA NDC Directory

Product NDC (as listed)70710-2169Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70710-2169Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70710-2169-8	7071021690870710216908	4 PATCH in 1 CARTON (70710-2169-8) / 7 d in 1 PATCH (70710-2169-1)Marketed from Nov 10, 2026

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Estradiol and Levonorgestrel
Generic name (nonproprietary): estradiol and levonorgestrel
Active ingredients: Estradiol — .045 mg/dLevonorgestrel — .015 mg/d
Dosage form: Patch
Route: Transdermal
Labeler: Zydus Pharmaceuticals USA Inc.NDC labeler code 70710
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 220407
Marketing start: Nov 10, 2026
Other FDA classes: Estradiol Congeners (Chemical structure)Estrogen Receptor Agonists (Mechanism)Inhibit Ovum Fertilization (Physiologic effect)Progesterone Congeners (Chemical structure)Progesterone Congeners (Chemical structure)
Identifiers: Product ID 70710-2169_ff28c70c-0323-43b0-83d7-1a2635a10193SPL ID ff28c70c-0323-43b0-83d7-1a2635a10193SPL set ID b143ebda-f5d7-4288-9a00-ba10a64f481fUNII 4TI98Z838E, 5W7SIA7YZW
Pharmacologic class: Estrogen; Progestin; Progestin-containing Intrauterine System

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Transdermal products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470710216908 followed by a unit qualifier and the quantity

Package 70710-2169-08. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 3, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

Estradiol and Levonorgestrel Transdermal System is indicated for: Estradiol and Levonorgestrel Transdermal System is an estrogen plus progestin indicated in a woman with a uterus for: Treatment of Moderate to Severe Vasomotor Symptoms due to Menopause ( 1.1 ) Prevention of Postmenopausal Osteoporosis ( 1.2 ) Limitations of Use : When prescribing solely for the prevention of postmenopausal osteoporosis, first consider the use of non-estrogen medications. Consider estrogen therapy only for women at significant risk of osteoporosis. 1.1 Treatment of Moderate to Severe Vasomotor Symptoms due to Menopause 1.2 Prevention of Postmenopausal Osteoporosis Limitation of Use When prescribing solely for …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 70710-2169

What is NDC 70710-2169?: 70710-2169 is the product NDC for Estradiol and Levonorgestrel, Estradiol .045 mg/d; Levonorgestrel .015 mg/d patch, listed with the FDA by Zydus Pharmaceuticals USA Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Estradiol and Levonorgestrel.
What is the active ingredient?: Estradiol, Levonorgestrel.
Who is the labeler?: Zydus Pharmaceuticals USA Inc., NDC labeler code 70710. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Estradiol and Levonorgestrel?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other NDCs under ANDA 220407

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 220407
Product	Strength	Form · route	Labeler	Product NDC
Estradiol and Levonorgestrel	Estradiol .045 mg/d; Levonorgestrel .015 mg/d	PatchTransdermal	Zydus Lifesciences Limited	70771-1992